FLAC

Frazier LifeSciences Acq... (FLAC)

Frazier LifeSciences Acquisition Corporation

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:FLAC

1 2 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2023/02/16	00 : 15	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:FLAC	Frazier LifeSciences Acquisition Corporation
2022/12/03	06 : 32	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(g) (15-12g)	NASDAQ:FLAC	Frazier LifeSciences Acquisition Corporation
2022/12/02	06 : 52	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:FLAC	Frazier LifeSciences Acquisition Corporation
2022/11/26	03 : 44	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:FLAC	Frazier LifeSciences Acquisition Corporation
2022/11/24	06 : 37	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:FLAC	Frazier LifeSciences Acquisition Corporation
2022/11/24	06 : 32	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:FLAC	Frazier LifeSciences Acquisition Corporation
2022/11/24	06 : 29	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:FLAC	Frazier LifeSciences Acquisition Corporation
2022/11/24	06 : 28	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:FLAC	Frazier LifeSciences Acquisition Corporation
2022/11/24	06 : 27	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:FLAC	Frazier LifeSciences Acquisition Corporation
2022/11/23	22 : 00	GlobeNewswire Inc.	NewAmsterdam Pharma Debuts as Publicly Traded Company Focused on Developing Obicetrapib, a Low-Dose, Once-Daily Oral LDL-Lowering Agent with Promising Safety and Efficacy Clinical Data, as a Potential Preferred Therapy for High Risk Cardiovascular Disease	NASDAQ:FLAC	Frazier LifeSciences Acquisition Corporation
2022/11/23	06 : 17	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)	NASDAQ:FLAC	Frazier LifeSciences Acquisition Corporation
2022/11/23	06 : 16	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)	NASDAQ:FLAC	Frazier LifeSciences Acquisition Corporation
2022/11/16	01 : 31	Business Wire	Frazier Lifesciences Acquisition Corporation Shareholders Approve Business Combination with NewAmsterdam Pharma Holding B.V.	NASDAQ:FLAC	Frazier LifeSciences Acquisition Corporation
2022/11/15	08 : 13	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:FLAC	Frazier LifeSciences Acquisition Corporation
2022/11/10	06 : 07	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:FLAC	Frazier LifeSciences Acquisition Corporation
2022/11/05	07 : 18	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:FLAC	Frazier LifeSciences Acquisition Corporation
2022/10/14	06 : 02	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:FLAC	Frazier LifeSciences Acquisition Corporation
2022/10/06	05 : 17	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:FLAC	Frazier LifeSciences Acquisition Corporation
2022/10/05	05 : 17	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:FLAC	Frazier LifeSciences Acquisition Corporation
2022/09/29	06 : 31	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:FLAC	Frazier LifeSciences Acquisition Corporation
2022/09/26	21 : 00	GlobeNewswire Inc.	Phathom Pharmaceuticals Appoints Dr. James Topper to its Board of Directors	NASDAQ:FLAC	Frazier LifeSciences Acquisition Corporation
2022/09/24	05 : 17	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:FLAC	Frazier LifeSciences Acquisition Corporation
2022/09/21	05 : 31	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:FLAC	Frazier LifeSciences Acquisition Corporation
2022/09/20	19 : 07	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:FLAC	Frazier LifeSciences Acquisition Corporation
2022/08/30	05 : 16	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:FLAC	Frazier LifeSciences Acquisition Corporation
2022/08/25	06 : 04	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:FLAC	Frazier LifeSciences Acquisition Corporation
2022/08/20	06 : 01	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:FLAC	Frazier LifeSciences Acquisition Corporation
2022/08/18	05 : 32	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:FLAC	Frazier LifeSciences Acquisition Corporation
2022/08/17	06 : 07	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:FLAC	Frazier LifeSciences Acquisition Corporation
2022/08/12	06 : 28	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:FLAC	Frazier LifeSciences Acquisition Corporation